Clinical Trials Logo

Adult T-Cell Lymphoma (ATL) clinical trials

View clinical trials related to Adult T-Cell Lymphoma (ATL).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02955589 Completed - Clinical trials for Adult T-Cell Lymphoma (ATL)

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)

Start date: November 2016
Phase: Phase 2
Study type: Interventional

Phase 2b, open-label, non-randomized, single arm study to evaluate the safety, and efficacy of HBI-8000 40 mg BIW in patients with relapsed or refractory ATL (R/R ATL)